Share

Safety, tolerability and metabolic profile of a Polglumyt®-based drink in single oral administration to healthy volunteers under fasting conditions

Project objectives

To investigate the safety, tolerability and metabolic profile of a Polglumyt®-based drink after a single oral administration to healthy volunteers.

Start and end date
2016 - 2017

Project Manager
Prof. Girogio Minotti, Head of Pharmaceutical Sciences UR, Università Campus Bio-Medico di Roma and Fondazione Policlinico Universitario Campus Bio-Medico, Rome - Principal Investigator
Prof. Pierantonio Menna, UR Clinical Pharmacology, Department of Science and Technology for Sustainable Development and One Health, Università Campus Bio-Medico di Roma; Campus Bio-Medico University Polyclinic Foundation - Co-Principal Investigator
prof Emanuela Salvatorelli, UR Pharmaceutical Sciences, Campus Bio-Medico University, Rome - Co-Principal Investigator

Coordinating institution of the project
UR Pharmaceutical Sciences, Departmental Faculty of Medicine and Surgery, Integrated Research Center, Campus Bio-Medico University, Rome

Funding source(s).
ACRAF SpA (Angelini Francesco Joint Chemical Companies)
2023© Università Campus Bio-Medico di Roma, Via Álvaro del Portillo, 21 - 00128 Rome, Tel. +39 06.22541.1, Fax +39 06.22541.456, VAT number: 048 020 51 005, Fiscal Code: 97087620585
magnifiercrossmenuchevron-downchevron-leftchevron-right